AlloVir Priced 20M Share Offering At $3.75/Share
Portfolio Pulse from Charles Gross
AlloVir has priced its underwritten public offering of 20 million shares at $3.75 per share, expecting to raise $75 million in gross proceeds. The offering is set to close on June 26, 2023, with J.P. Morgan, Morgan Stanley, and BofA Securities as joint book-running managers.
June 22, 2023 | 1:23 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
AlloVir's stock price may be impacted by the pricing of its 20 million share offering at $3.75 per share, which aims to raise $75 million in gross proceeds.
The announcement of AlloVir's share offering may have a short-term impact on its stock price. The pricing of the offering at $3.75 per share could influence investor sentiment and trading activity. However, the overall impact on the stock price will depend on market conditions and investor reactions to the news.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100